Author

Fabio Duranti

Observed name: F. Duranti

Institutions: IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna

Observed institutions: University of Rome Tor Vergata, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Policlinico Tor Vergata, University of Bologna

ORCID: 0000-0002-8677-5493

Observed ORCID: 0000-0002-8677-5493

OpenAlex ID: A5089704259

Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesis

2013 · Fabio Duranti, Massimo Pieri, et al. · Journal of Neuroimmunology · 84

Clinical characterization of status epilepticus in childhood: a retrospective study in 124 patients

2020 · D. Chiarello, F. Duranti, et al. · Seizure · 9

PDF

Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence‐Jones in nephelometry?

2015 · Massimo Pieri, Alessandro De Stefano, et al. · British Journal of Haematology · 8

PDF

Emoglobina glicata in base al genere: possibili valori di riferimento

2015 · Massimo Pieri, Francesca Gabriela Martino, et al. · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · 1

K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis

2014 · Massimo Pieri, Fabio Duranti, et al. · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · 1

Cerebrospinal Fluid: Novel Developed Biomarkers in Neurological Disease

2014 · Mariarita Dessı̀, Fabio Duranti, et al. · Cineca Institutional Research Information System (Tor Vergata University)

MRD-Directed Post-Remissional Therapy Dramatically Improves Outcome of Adult Patients with High Risk AML by Implementing Allogeneic Transplant Option

2010 · Francesco Buccisano, Luca Maurillo, et al. · Blood

Works count: 7

Citation count: 103

H-index: 3

I10-index: 1